MXPA01009992A - Absorbent tissues providing skin barrier enhancement - Google Patents
Absorbent tissues providing skin barrier enhancementInfo
- Publication number
- MXPA01009992A MXPA01009992A MXPA/A/2001/009992A MXPA01009992A MXPA01009992A MX PA01009992 A MXPA01009992 A MX PA01009992A MX PA01009992 A MXPA01009992 A MX PA01009992A MX PA01009992 A MXPA01009992 A MX PA01009992A
- Authority
- MX
- Mexico
- Prior art keywords
- weight
- oil
- composition
- clause
- product
- Prior art date
Links
- 210000001519 tissues Anatomy 0.000 title claims abstract description 98
- 210000003491 Skin Anatomy 0.000 title claims abstract description 92
- 230000002745 absorbent Effects 0.000 title description 29
- 239000002250 absorbent Substances 0.000 title description 29
- 239000000203 mixture Substances 0.000 claims abstract description 191
- 235000003702 sterols Nutrition 0.000 claims abstract description 66
- 150000003432 sterols Chemical class 0.000 claims abstract description 63
- 239000004094 surface-active agent Substances 0.000 claims abstract description 27
- 239000003974 emollient agent Substances 0.000 claims abstract description 26
- 150000002632 lipids Chemical class 0.000 claims abstract description 26
- 239000003906 humectant Substances 0.000 claims abstract description 25
- 230000001804 emulsifying Effects 0.000 claims abstract description 20
- 230000002708 enhancing Effects 0.000 claims abstract description 13
- 239000003623 enhancer Substances 0.000 claims abstract description 7
- 230000001815 facial Effects 0.000 claims abstract description 6
- 238000009826 distribution Methods 0.000 claims abstract description 5
- 239000008247 solid mixture Substances 0.000 claims abstract 2
- 239000003921 oil Substances 0.000 claims description 115
- 235000019198 oils Nutrition 0.000 claims description 107
- 239000001993 wax Substances 0.000 claims description 41
- 239000003925 fat Substances 0.000 claims description 29
- 235000019197 fats Nutrition 0.000 claims description 29
- -1 polyethylene Polymers 0.000 claims description 28
- 239000004264 Petrolatum Substances 0.000 claims description 25
- 229940066842 Petrolatum Drugs 0.000 claims description 25
- 235000019271 petrolatum Nutrition 0.000 claims description 25
- 230000035515 penetration Effects 0.000 claims description 22
- 235000011187 glycerol Nutrition 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 238000002844 melting Methods 0.000 claims description 21
- CWMMCBXYWVPWJL-FNORWQNLSA-N (E)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one Chemical compound COC1=CC(OC)=CC=C1\C=C\C(=O)C1=C(O)C=C(O)C=C1OC CWMMCBXYWVPWJL-FNORWQNLSA-N 0.000 claims description 20
- 230000002209 hydrophobic Effects 0.000 claims description 18
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical group CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 17
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 16
- 229940012831 stearyl alcohol Drugs 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 13
- 239000004698 Polyethylene (PE) Substances 0.000 claims description 11
- 229940033331 Soy Sterol Drugs 0.000 claims description 11
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 11
- 229920000573 polyethylene Polymers 0.000 claims description 11
- 235000021302 avocado oil Nutrition 0.000 claims description 10
- 239000008163 avocado oil Substances 0.000 claims description 10
- 235000021324 borage oil Nutrition 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 10
- NOPFSRXAKWQILS-UHFFFAOYSA-N Docosanol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 9
- 239000004166 Lanolin Substances 0.000 claims description 9
- 229940039717 Lanolin Drugs 0.000 claims description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 9
- NWGKJDSIEKMTRX-MDZDMXLPSA-N Sorbitan oleate Chemical group CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O NWGKJDSIEKMTRX-MDZDMXLPSA-N 0.000 claims description 9
- 229950004959 Sorbitan oleate Drugs 0.000 claims description 9
- 239000004147 Sorbitan trioleate Substances 0.000 claims description 9
- 229960000391 Sorbitan trioleate Drugs 0.000 claims description 9
- PRXRUNOAOLTIEF-XDTJCZEISA-N [2-[(2R,3S,4R)-4-hydroxy-3-[(Z)-octadec-9-enoyl]oxyoxolan-2-yl]-2-[(Z)-octadec-9-enoyl]oxyethyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@@H](O)[C@@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-XDTJCZEISA-N 0.000 claims description 9
- 229960000735 docosanol Drugs 0.000 claims description 9
- 235000019388 lanolin Nutrition 0.000 claims description 9
- 239000004200 microcrystalline wax Substances 0.000 claims description 9
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 9
- 235000019337 sorbitan trioleate Nutrition 0.000 claims description 9
- 229940107161 Cholesterol Drugs 0.000 claims description 8
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 8
- 235000012000 cholesterol Nutrition 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 239000002480 mineral oil Substances 0.000 claims description 8
- 235000010446 mineral oil Nutrition 0.000 claims description 8
- 235000012424 soybean oil Nutrition 0.000 claims description 8
- 239000003549 soybean oil Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 7
- 229940067631 Phospholipids Drugs 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- 230000004888 barrier function Effects 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 7
- 230000001965 increased Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 150000003904 phospholipids Chemical class 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 235000010356 sorbitol Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 229950011392 Sorbitan stearate Drugs 0.000 claims description 6
- 235000019486 Sunflower oil Nutrition 0.000 claims description 6
- HVUMOYIDDBPOLL-IIZJTUPISA-N [2-[(2R,3S,4R)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@@H](O)[C@@H]1O HVUMOYIDDBPOLL-IIZJTUPISA-N 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 6
- 235000019438 castor oil Nutrition 0.000 claims description 6
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 239000002600 sunflower oil Substances 0.000 claims description 6
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N 1-Tetradecanol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 5
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 claims description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 5
- LQZZUXJYWNFBMV-UHFFFAOYSA-N Dodecanol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 5
- 240000008426 Persea americana Species 0.000 claims description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 5
- 235000021355 Stearic acid Nutrition 0.000 claims description 5
- 229960000541 cetyl alcohol Drugs 0.000 claims description 5
- 235000019864 coconut oil Nutrition 0.000 claims description 5
- 239000003240 coconut oil Substances 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- 239000006260 foam Substances 0.000 claims description 5
- 239000010514 hydrogenated cottonseed oil Substances 0.000 claims description 5
- 229940043348 myristyl alcohol Drugs 0.000 claims description 5
- 235000005426 persea americana Nutrition 0.000 claims description 5
- 239000008117 stearic acid Substances 0.000 claims description 5
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 4
- 244000144730 Amygdalus persica Species 0.000 claims description 4
- 235000021314 Palmitic acid Nutrition 0.000 claims description 4
- 229940005581 Sodium Lactate Drugs 0.000 claims description 4
- NGSFWBMYFKHRBD-UHFFFAOYSA-M Sodium lactate Chemical compound [Na+].CC(O)C([O-])=O NGSFWBMYFKHRBD-UHFFFAOYSA-M 0.000 claims description 4
- 239000010495 camellia oil Substances 0.000 claims description 4
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 235000012343 cottonseed oil Nutrition 0.000 claims description 4
- 229940075529 glyceryl stearate Drugs 0.000 claims description 4
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 claims description 4
- 235000020778 linoleic acid Nutrition 0.000 claims description 4
- 239000012170 montan wax Substances 0.000 claims description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N rac-1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- 239000010667 rosehip oil Substances 0.000 claims description 4
- 235000005713 safflower oil Nutrition 0.000 claims description 4
- 239000001540 sodium lactate Substances 0.000 claims description 4
- 235000011088 sodium lactate Nutrition 0.000 claims description 4
- CRPCXAMJWCDHFM-DFWYDOINSA-M sodium;(2S)-5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)[C@@H]1CCC(=O)N1 CRPCXAMJWCDHFM-DFWYDOINSA-M 0.000 claims description 4
- DNVPQKQSNYMLRS-APGDWVJJSA-N Ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-APGDWVJJSA-N 0.000 claims description 3
- DNVPQKQSNYMLRS-LNHMRCHQSA-N Ergosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3C([C@H]4[C@@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)=CC=2)CC1 DNVPQKQSNYMLRS-LNHMRCHQSA-N 0.000 claims description 3
- 229940042472 Mineral Oil Drugs 0.000 claims description 3
- 239000010480 babassu oil Substances 0.000 claims description 3
- 230000001010 compromised Effects 0.000 claims description 3
- 239000002385 cottonseed oil Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 claims description 3
- 239000003346 palm kernel oil Substances 0.000 claims description 3
- 235000019865 palm kernel oil Nutrition 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229920000098 polyolefin Polymers 0.000 claims description 3
- 229920005672 polyolefin resin Polymers 0.000 claims description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 2
- 235000007639 Anthemis cotula Nutrition 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 229940089020 Evening primrose oil Drugs 0.000 claims description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 2
- 229960005078 Sorbitan sesquioleate Drugs 0.000 claims description 2
- IJCWFDPJFXGQBN-BIFNRIDTSA-N Sorbitan tristearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@@H](O)[C@@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-BIFNRIDTSA-N 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 235000001544 chamomile Nutrition 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000001589 sorbitan tristearate Substances 0.000 claims description 2
- 235000011078 sorbitan tristearate Nutrition 0.000 claims description 2
- 229960004129 sorbitan tristearate Drugs 0.000 claims description 2
- 235000019489 Almond oil Nutrition 0.000 claims 1
- 240000000218 Cannabis sativa Species 0.000 claims 1
- 240000006223 Matricaria chamomilla Species 0.000 claims 1
- 240000005158 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 235000009120 camo Nutrition 0.000 claims 1
- 235000005607 chanvre indien Nutrition 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 239000011487 hemp Substances 0.000 claims 1
- 235000012765 hemp Nutrition 0.000 claims 1
- 235000012766 marijuana Nutrition 0.000 claims 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical group OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 239000002253 acid Substances 0.000 description 14
- 238000004140 cleaning Methods 0.000 description 10
- 238000010348 incorporation Methods 0.000 description 9
- 235000020238 sunflower seed Nutrition 0.000 description 9
- 230000036572 transepidermal water loss Effects 0.000 description 9
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 7
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 150000002191 fatty alcohols Chemical class 0.000 description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 5
- 229940042585 Tocopherol Acetate Drugs 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- UCYLROVJSUACAD-UHFFFAOYSA-N 2-[2,3-bis(2-hydroxyethoxy)propoxy]ethanol Chemical compound OCCOCC(OCCO)COCCO UCYLROVJSUACAD-UHFFFAOYSA-N 0.000 description 4
- 206010000496 Acne Diseases 0.000 description 4
- VLPFTAMPNXLGLX-UHFFFAOYSA-N Axona Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 4
- 210000000245 Forearm Anatomy 0.000 description 4
- 240000007842 Glycine max Species 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 239000010466 nut oil Substances 0.000 description 4
- 239000010502 orange oil Substances 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 4
- 238000009736 wetting Methods 0.000 description 4
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 3
- 241000273930 Brevoortia tyrannus Species 0.000 description 3
- 206010049796 Excoriation Diseases 0.000 description 3
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 3
- XUGNVMKQXJXZCD-UHFFFAOYSA-N Isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- 235000019502 Orange oil Nutrition 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 241000209149 Zea Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 235000019519 canola oil Nutrition 0.000 description 3
- 239000000828 canola oil Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 235000005824 corn Nutrition 0.000 description 3
- 229940075495 isopropyl palmitate Drugs 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 230000004625 regulation of water loss via skin Effects 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241001116389 Aloe Species 0.000 description 2
- 229940069521 Aloe Extract Drugs 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N Arachidic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 210000001124 Body Fluids Anatomy 0.000 description 2
- 229940073532 Candelilla Wax Drugs 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 240000007170 Cocos nucifera Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 229960001031 Glucose Drugs 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N Hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N Lauric acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 210000004400 Mucous Membrane Anatomy 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N Nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 229940100515 SORBITAN Drugs 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N Saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940081974 Saccharin Drugs 0.000 description 2
- 229940069764 Shark liver oil Drugs 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Stearin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 229940032091 Stigmasterol Drugs 0.000 description 2
- HCXVJBMSMIARIN-MFBJGPNFSA-N Stigmasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@@H](/C=C/[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 HCXVJBMSMIARIN-MFBJGPNFSA-N 0.000 description 2
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N Tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- 240000008529 Triticum aestivum Species 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 230000000996 additive Effects 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000012182 japan wax Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000003020 moisturizing Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000003252 repetitive Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 239000010670 sage oil Substances 0.000 description 2
- 239000010686 shark liver oil Substances 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- 230000037067 skin hydration Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 235000021307 wheat Nutrition 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- HBOQXIRUPVQLKX-BBWANDEASA-N 1,2,3-trilinoleoylglycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COC(=O)CCCCCCC\C=C/C\C=C/CCCCC HBOQXIRUPVQLKX-BBWANDEASA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinone Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- MWKFXSUHUHTGQN-UHFFFAOYSA-N 1-Decanol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- QNESDXMHQYMNGD-UHFFFAOYSA-N 2,3-bis(3,5,5-trimethylhexanoyloxy)propyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CC(=O)OCC(OC(=O)CC(C)CC(C)(C)C)COC(=O)CC(C)CC(C)(C)C QNESDXMHQYMNGD-UHFFFAOYSA-N 0.000 description 1
- RIXCYAQOGLLEIU-OTDRRXFESA-N 2,3-bis[[(E)-12-acetyloxyoctadec-9-enoyl]oxy]propyl (E)-12-acetyloxyoctadec-9-enoate Chemical compound CCCCCCC(OC(C)=O)C\C=C\CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C\CC(CCCCCC)OC(C)=O)COC(=O)CCCCCCC\C=C\CC(CCCCCC)OC(C)=O RIXCYAQOGLLEIU-OTDRRXFESA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- RZCHTMXTKQHYDT-UHFFFAOYSA-N 2-hydroxy-N-(2-hydroxyethyl)propanamide Chemical compound CC(O)C(=O)NCCO RZCHTMXTKQHYDT-UHFFFAOYSA-N 0.000 description 1
- FGYZAECYNNGYAN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;propane-1,2-diol Chemical compound CC(O)CO.OC(=O)CC(O)(C(O)=O)CC(O)=O FGYZAECYNNGYAN-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-M 2-hydroxystearate Chemical compound CCCCCCCCCCCCCCCCC(O)C([O-])=O KIHBGTRZFAVZRV-UHFFFAOYSA-M 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-hydroxystearic acid Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- MBZYKEVPFYHDOH-BQNIITSRSA-N 24,25-dihydrolanosterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@]21C MBZYKEVPFYHDOH-BQNIITSRSA-N 0.000 description 1
- WHDZFABLYCTYDP-UHFFFAOYSA-N 5-oxopyrrolidine-2-carboxylate;tris(2-hydroxyethyl)azanium Chemical compound OC(=O)C1CCC(=O)N1.OCCN(CCO)CCO WHDZFABLYCTYDP-UHFFFAOYSA-N 0.000 description 1
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N 7-Dehydrocholesterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 1
- 240000006523 Abies balsamea Species 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 240000001101 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 229940061720 Alpha Hydroxy Acids Drugs 0.000 description 1
- 235000001274 Anacardium occidentale Nutrition 0.000 description 1
- 240000001407 Anacardium occidentale Species 0.000 description 1
- 229940114079 Arachidonic Acid Drugs 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N Arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 229940005787 Behenyl benzoate Drugs 0.000 description 1
- 241000157302 Bison bison athabascae Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 229940072104 CHOLESTERYL HYDROXYSTEARATE Drugs 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 229940106189 Ceramides Drugs 0.000 description 1
- 210000003756 Cervix Mucus Anatomy 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229940107111 Cholecalciferol Drugs 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000003472 Citrus aurantium Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 229940096386 Coconut Alcohol Drugs 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 240000001644 Cola acuminata Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 240000006775 Enicostema verticillatum Species 0.000 description 1
- 229960002061 Ergocalciferol Drugs 0.000 description 1
- 229940044949 Eucalyptus oil Drugs 0.000 description 1
- 210000000416 Exudates and Transudates Anatomy 0.000 description 1
- 210000003608 Feces Anatomy 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 229940097043 Glucuronic Acid Drugs 0.000 description 1
- 229940049906 Glutamate Drugs 0.000 description 1
- 229960002989 Glutamic Acid Drugs 0.000 description 1
- 240000001340 Gmelina philippensis Species 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 241001184005 Hyptis Species 0.000 description 1
- 235000015912 Impatiens biflora Nutrition 0.000 description 1
- 210000003093 Intracellular Space Anatomy 0.000 description 1
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- SXQFCVDSOLSHOQ-UHFFFAOYSA-N Lactamide Chemical compound CC(O)C(N)=O SXQFCVDSOLSHOQ-UHFFFAOYSA-N 0.000 description 1
- 229940001447 Lactate Drugs 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- 229940058690 Lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-DFHJLLNLSA-N Lanosterol Natural products C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@]21C CAHGCLMLTWQZNJ-DFHJLLNLSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 240000001422 Laurus nobilis Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229960004488 Linolenic Acid Drugs 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229940100485 METHYL GLUCETH-10 Drugs 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 235000012629 Mentha aquatica Nutrition 0.000 description 1
- 240000007707 Mentha arvensis Species 0.000 description 1
- 235000018978 Mentha arvensis Nutrition 0.000 description 1
- 240000006217 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000016247 Mentha requienii Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000002901 Mentha sylvestris Nutrition 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000008188 Monarda punctata Species 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- PVCJKHHOXFKFRP-UHFFFAOYSA-N N-acetylethanolamine Chemical compound CC(=O)NCCO PVCJKHHOXFKFRP-UHFFFAOYSA-N 0.000 description 1
- 210000001331 Nose Anatomy 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N Oleyl alcohol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 235000006297 Origanum majorana Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 235000011829 Ow cola Nutrition 0.000 description 1
- 229940097407 PALM KERNEL ACID Drugs 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- 241001516747 Pentadesma Species 0.000 description 1
- 102000035443 Peptidases Human genes 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 241000390166 Physaria Species 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 210000002826 Placenta Anatomy 0.000 description 1
- 229920000582 Polyisocyanurate Polymers 0.000 description 1
- 235000002343 Primula veris Nutrition 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 240000003122 Primula vulgaris Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 240000002799 Prunus avium Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 241000410027 Psacalium Species 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-N Ricinoleic acid Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O WBHHMMIMDMUBKC-QJWNTBNXSA-N 0.000 description 1
- WBHHMMIMDMUBKC-GKUQOKNUSA-N Ricinoleic acid Natural products CCCCCC[C@H](O)C\C=C/CCCCCCCC(O)=O WBHHMMIMDMUBKC-GKUQOKNUSA-N 0.000 description 1
- 235000004097 Rosa arvensis Nutrition 0.000 description 1
- 235000000657 Rosa moschata Nutrition 0.000 description 1
- 244000018676 Rosa sp Species 0.000 description 1
- 235000009791 Rosa sp Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 240000005481 Salvia hispanica Species 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- 235000006095 Salvia sylvestris Nutrition 0.000 description 1
- 235000006145 Salvia verbenaca Nutrition 0.000 description 1
- 229940057910 Shea butter Drugs 0.000 description 1
- 229940098780 TRIBEHENIN Drugs 0.000 description 1
- 229940057400 TRIHYDROXYSTEARIN Drugs 0.000 description 1
- 229940116962 TRIISONONANOIN Drugs 0.000 description 1
- 229940098385 TRIISOSTEARIN Drugs 0.000 description 1
- 229940111630 Tea Tree Oil Drugs 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 235000004652 Tilia americana var heterophylla Nutrition 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- 235000015450 Tilia cordata Nutrition 0.000 description 1
- 235000010840 Tilia tomentosa Nutrition 0.000 description 1
- 229940117972 Triolein Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N Undecylenic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 210000002268 Wool Anatomy 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 Xylitol Drugs 0.000 description 1
- UYCAGRPOUWSBIQ-WOYAITHZSA-N [(1S)-1-carboxy-4-(diaminomethylideneamino)butyl]azanium;(2S)-5-oxopyrrolidine-2-carboxylate Chemical compound OC(=O)[C@@H]1CCC(=O)N1.OC(=O)[C@@H](N)CCCN=C(N)N UYCAGRPOUWSBIQ-WOYAITHZSA-N 0.000 description 1
- NWGKJDSIEKMTRX-HSACVWGTSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (E)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-HSACVWGTSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- LOBPJJIUYOJZHH-ROOYBKPPSA-N [[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-[[[2,3-di(hexadecanoyloxy)propoxycarbonyloxymethoxy-hydroxyphosphoryl]-difluoromethyl]-hydroxyphosphoryl]oxyphosphoryl]boron(1-) Chemical compound C1[C@H](N=[N+]=[N-])[C@@H](CO[P@@](=O)([B-])OP(O)(=O)C(F)(F)P(O)(=O)OCOC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)O[C@H]1N1C(=O)NC(=O)C(C)=C1 LOBPJJIUYOJZHH-ROOYBKPPSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000001269 achillea millefolium l. oil Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000000843 anti-fungal Effects 0.000 description 1
- 230000000845 anti-microbial Effects 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 230000002421 anti-septic Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000003952 beebalm Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 235000006682 bigleaf mint Nutrition 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000010623 birch oil Substances 0.000 description 1
- 235000015386 bitter orange Nutrition 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 235000012377 chia Nutrition 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 230000001112 coagulant Effects 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019516 cod Nutrition 0.000 description 1
- 229960004729 colecalciferol Drugs 0.000 description 1
- 230000003750 conditioning Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 201000004624 dermatitis Diseases 0.000 description 1
- XMXOIHIZTOVVFB-JIZZDEOASA-L disodium;(2S)-2-aminobutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CC([O-])=O XMXOIHIZTOVVFB-JIZZDEOASA-L 0.000 description 1
- 229950008690 docosanoic acid Drugs 0.000 description 1
- IACXYDVFQDGXJF-UHFFFAOYSA-N docosyl benzoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 IACXYDVFQDGXJF-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 239000010645 fir oil Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940055015 glycereth-20 Drugs 0.000 description 1
- 229940088638 glycereth-7 Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 239000010460 hemp oil Substances 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000000175 humulus lupulus l. cone oil Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000010512 hydrogenated peanut oil Substances 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000003522 irritant Effects 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- CAHGCLMLTWQZNJ-BQNIITSRSA-N lanosterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H](CCC=C(C)C)C)CC[C@]21C CAHGCLMLTWQZNJ-BQNIITSRSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M laurate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 102000004882 lipase Human genes 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 108090001060 lipase Proteins 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001780 majorana hortensis moench (origanum majorana l.) Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000457 mentha pulegium l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000006679 mint Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000010658 moringa oil Substances 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- KPWVFNOPNOTYNJ-UHFFFAOYSA-N octadecyl benzoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 KPWVFNOPNOTYNJ-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000012168 ouricury wax Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000006678 peppermint Nutrition 0.000 description 1
- 235000015132 peppermint Nutrition 0.000 description 1
- 235000007735 peppermint Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 239000001794 pinus palustris tar oil Substances 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- 239000010465 pomace olive oil Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001327 prunus amygdalus amara l. extract Substances 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010671 sandalwood oil Substances 0.000 description 1
- 239000010672 sassafras oil Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000004458 spent grain Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000000475 sunscreen Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 239000002641 tar oil Substances 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000003106 tissue adhesive Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229940093633 tricaprin Drugs 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- PJHKBYALYHRYSK-UHFFFAOYSA-N triheptanoin Chemical compound CCCCCCC(=O)OCC(OC(=O)CCCCCC)COC(=O)CCCCCC PJHKBYALYHRYSK-UHFFFAOYSA-N 0.000 description 1
- 229940078561 triheptanoin Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940081852 trilinolein Drugs 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical class CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229960001947 tripalmitin Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N β-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
Abstract
A skin barrier-enhancing tissue product, such as facial tissue, bath tissue or paper towels and the like, can be made by applying, on the surface(s) of the tissue, a lipid-enriched melted oil based-hydrophobic composition comprising a natural fat or oil, a sterol or sterol derivative, an emulsifying surfactant having an HLB range from about 3 to about 6, a humectant, an emollient, a wax, and a viscosity enhancer, and thereafter resolidifying the composition to form a distribution of solid composition on the surface(s) of the tissue.
Description
ABSORBENT TISSUES THAT PROVIDE AN INCREMENT OF SKIN BARRIER
Field of the Invention
The present invention relates to the inclusion of a hydrophobic lotion enriched with lipids on absorbent tissue products, such as facial tissue, bath tissue, paper towels and the like. More particularly, the present invention relates to the increase of a skin barrier function by the delivery of hydrophobic oil-based compositions from the absorbent tissue products to the skin.
Background of the Invention
The stratum corneum is the outermost layer of the skin and is responsible for the regulation of water levels in the skin and acts as a barrier against chemicals and other stressors found in the environment. The complex arrangement of lipids in the intracellular space of the stratum corneum is responsible for the establishment of a normal barrier function. The multi-layered structures of cholesterol, ceramides, and fatty acids, as well as some other minor lipids, provide the main barrier to the transport of hydrophilic substances in or through the skin. The link between barrier function and skin health is evident from the inflammation of the skin caused by the extraction of lipid from the skin.
The skin barrier can be damaged due to a number of mechanisms. Physical abrasion, for example caused by the repeated rubbing of absorbent tissue products on the skin, removes layers of the skin and therefore damages the skin barrier. Biological fluids, such as urine, feces, nasal and vaginal secretions, may contain a variety of components that can damage the skin barrier. Examples of these components include proteases, lipases, bile acids, and fatty acids. Once the skin barrier is compromised, these components, in addition to other constituents of biological fluids, can initiate or exacerbate skin inflammation.
Excessive hydration also has a negative impact on the skin barrier. Frequent skin contact with fluids such as nasal discharge can contribute to increased skin hydration. The increased skin hydration disrupts the lipid organization of the skin in the stratum corneum. This interruption can increase the permeability of the skin of the irritants, and therefore increasing the risk of inflammation of the skin.
Absorbent tissue products such as facial tissue and tissue paper have been used to absorb body fluids and leave skin dry. The absorbent tissue, in addition to absorbing the fluids, however, also scrapes the skin during use and frequently does not leave the skin completely dry and free of the body fluid that is trying to absorb the tissue. During the frequent sounding of the nose or perianal cleansing, for example, the skin may be scratched enough to appear red and painful to the touch. To reduce skin abrasion, tissue adhesive formulas can be applied to the tissue so that, in use, the additive formula either provides lubricity by causing the tissue to slip across the surface of the skin, or the tissue and deposit on the skin.
Once deposited on the skin, these additive formulas provide a benefit to the skin by occluding the skin. Therefore, these formulas provide a short-term benefit by providing an artificial barrier, even when the underlying stratum corneum has still been damaged.
Therefore, what is required in the art is a chemical formula that when applied from an absorbent tissue, increases the barrier function of the skin by delivering a lipid chemistry while minimizing physical damage caused by rubbing the skin. absorbent tissue on the surface of the skin.
Synthesis of the Invention
It has now been discovered that the skin barrier-enhancing absorbent tissue product can be made by applying, on the tissue, an hydrophobic oil-based composition comprising a natural oil or fat, a sterol or sterol derivative, a humectant, an emulsifying surfactant having a hydrophilic and lipophilic balance range of from about 3 to about 6, an emollient, a wax, and optionally a viscosity enhancer and then resolidifying the composition to form a distribution, preferably a uniform distribution , of solid deposits on the surface or surfaces of the tissue. Because the composition is a solid at room temperature and solidifies rapidly after deposit, it has a tendency to penetrate and migrate into the sheet. Compared to the tissues treated with the liquid formulas, it leaves a larger percentage of the anhydrous solid lotion composition added on the surface of the tissue where it can make contact and transfer to the user's skin to provide increased skin health benefits. . In addition, a lower aggregate amount may be used to deliver the same benefit at a lower cost due to the efficient placement of the composition essentially on the surface of the product.
Therefore, in one aspect, the present invention relates to an oil-based hydrophobic composition comprising from about 0.1 to about 95% by weight of natural oils or fats, from about 0.1 to about 10% by weight. weight of sterols or sterol derivatives, from about 0.5 to about 20% by weight of humectant, from about 1 to about 20% by weight of a water-in-oil emulsifier surfactant having a range of hydrophilic and lipophilic balance of from about 3 to about 6, from about 5% by weight to about 95% by weight of emollient, from about 5% by weight to about 95% by weight of wax, and optionally from about 0% by weight to about 25% by weight of viscosity increaser. The composition may have a melting point of from about 30 ° C to about 100 ° C and a process viscosity of more than about 50 centipoise. Also the composition can have a penetration hardness of from about 5 millimeters to 360 millimeters.
In another aspect, the invention resides in a tissue or towel product wherein one or both of the outer surfaces of the product have solidified deposits of an hydrophobic, oil-based composition comprising from about 0.1 to about 95% by weight. weight of natural oils or fats, from about 0.1 to about 10% by weight of sterol or sterol derivative, from about 0.5 to about 20% by weight of a humectant, from about 1 to about 20% by weight of a water-in-oil emulsifier surfactant having a hydrophilic-lipophilic balance range of from about 3 to about 6, from about 5% by weight to about 95% by weight of emollient, from about 5% by weight to about 95% by weight of wax and optionally from about 0% by weight to about 25% by weight of viscosity increaser. The composition may have a melting / freezing point of from about 30 ° C to about 100 ° C and a process viscosity of more than about 50 centipoise. Also, the composition can have a penetration hardness of from about 5 millimeters penetration to 360 millimeters penetration.
In another aspect, the invention resides in a method for making a tissue or towel product comprising: (a) heating the skin barrier increasing composition comprising a fat or oil, a sterol or a sterol derivative , a humectant, a water-in-oil emulsifying surfactant having the range of hydrophilic-lipophilic balance of from about 3 to about 6, an emollient, a wax and optionally a viscosity increaser at a temperature above the melting point of the composition, causing the composition to melt; (b) uniformly applying the molten composition to one or both surfaces of the towel or tissue tissue in separate and spaced tanks; and (c) resolidifying the deposits of the molten composition. The composition may have a melting point ranging from about 30 ° C to about 100 ° C.
Detailed description of the invention
An embodiment of the present invention relates to a tissue or towel product having two exterior surfaces. One or both of the outer surfaces of the product have solidified deposits of a composition that improves the skin barrier. The composition may comprise from about 0.1 to about 95% by weight of natural oils or fats, from about 0.1% by weight to about 10% by weight of sterols or sterol derivatives, from about 1 to about 20% by weight of a water-in-oil emulsifier surfactant having a hydrophilic-lipophilic balance range of from about 3 to about 6, from about 0.5 to about 20% by weight of humectant , from about 5 to about 95% by weight of emollient, from about 5 to about 95% by weight of wax, and from about 0% by weight to about 25% by weight of an improver of viscosity.
The composition may have a melting point of from about 30 ° C to about 100 ° C. The composition may have a penetration hardness of from about 5 millimeters to about 360 millimeters. The aggregate amount of the composition is from about 0.5 to about 30% by weight based on the weight of said product. The aggregate amount of the composition can also be expressed as from about 0.1 grams per square meter (g / m2) to about 30 g / m2 of the tissue or towel product, and more preferably from about 0.5 g / m2. m2 to around 25 g / m2.
The oil or natural fat used in the composition may include sunflower seed oil, borage oil, or avocado oil. The sterol or sterol derivative used in the composition may include soy sterol, cholesterol or sterol wool. The humectant used in the composition may include glycerin, sorbitol or starch hydrolyzate. The emulsifying surfactant employed in the composition may include sorbitan oleate, sorbitan trioleate or sorbitan stearate. The emollient used in the composition can include petrolatum, mineral oil or stearyl alcohol. The wax used in the composition could include ozzoserin wax or microcrystalline wax. The viscosity increaser used and the composition may include polyethylene or ethylene / vinyl acetate copolymer.
Another embodiment of the present invention is a method for making a tissue or towel product having two exterior surfaces comprising: (a) heating a composition that increases the skin barrier comprising a fat or natural oil, sterol or derivative of sterol, a humectant, an emulsifying surfactant having a hydrophilic-lipophilic balance range of from about 3 to about 6, an emollient, a wax, and a viscosity increaser, at a temperature above the melting point of the composition , making the composition melt; (b) applying the molten composition to one or both surfaces of a tissue of tissue or towel in separate spaced tanks; and (c) resolidifying said deposits of the molten composition.
The composition may have a melting point of from about 30 ° C to about 100 ° C. The resolidified composition can have a penetration hardness of from about 5 to about 360 millimeters. The molten composition can be applied by means of printing.
Another embodiment of the present invention is a skin barrier enhancing composition comprising from about 0.1% by weight to about 95% by weight of natural oils or fats, from about 0.1% by weight to about 10%. by weight of sterol or sterol derivative, from about 1% by weight to about 20% by weight of a water-in-oil emulsifying surfactant having a hydrophilic-lipophilic balance range of from about 3 to about 6, from about 0.5% by weight to about 20% by weight of humectant, from about 5% by weight to about 95% by weight of an emollient, from about 5% by weight to about 95% by weight of wax and from about 0% by weight to about 25% by weight of the viscosity increaser.
The composition may have a melting point of from about 30 ° C to about 100 ° C. The resolidified composition can have a penetration hardness of from about 5 millimeters to about 360 millimeters.
The fat or natural oil of the composition can be selected from the group consisting of avocado oil, peach oil, babassu oil, borage oil, camellia oil, canola oil, castor oil, chamomile, coconut oil, corn oil, cottonseed oil, afternoon primrose oil, hemp oil, hydrogenated cottonseed oil, hydrogenated palm kernel oil, beaten soybean oil, prairie foam oil, kernel oil palm, phospholipids, kolza seed oil, palmitic acid, stearic acid, linoleic acid, rose hip oil, safflower, sunflower seed oil, soybean oil, sweet almond, PROLIPID 141 (proprietary mixture of glyceryl stearate, acids fatty, fatty alcohols and phospholipids) or derived from natural fats or oils (such as stearyl alcohol, lauryl alcohol, myristyl alcohol and benenyl alcohol, and the like), and mixtures thereof. (PROLIPID is commercially available from International Specialty Products located in Wayne, New Jersey, PROLIPID is generally described in United States Patent No. 5,849,315 issued to Rerek et al. On December 15, 1998, which is incorporated here by reference to the extent that it is consistent with it.)
The sterol or sterol derivative of the composition can be selected from the group consisting of: cholesterol, cytosterol, stigmasterol, ergosterol, lanasterol, soy sterol, avocado sterols, sterol esters, and the like, as well as mixtures thereof. The emulsifying surfactant of the composition may be selected from the group consisting of: sorbitan oleate, sorbitan sesquioleate, sorbitan stearate, sorbitan sorbrate, sorbitan trioleate, and the like as well as mixtures thereof.
The humectant of the composition can be selected from the group consisting of: glycerin, hydrogenated starch hydrolyzate, propylene glycol, sodium PCA, sodium lactate, sorbitol, and the like, as well as mixtures thereof. The emollient of the composition may be selected from the group consisting of: mineral oil, petrolatum, stearyl alcohol, cetearyl alcohol, cetyl alcohol, behenyl alcohol, octyldodecanol, cosmetic esters, and the like as well as mixtures thereof.
The wax of the composition can be selected from the group consisting of: carnuba, crassin, cetyl esters, microcrystalline wax, montan wax, ozokerite, synthetic wax, and the like, as well as mixtures thereof. The viscosity increaser of the composition may be selected from the group consisting of: polyolefin resins, polyolefin polymers, ethylene / vinyl acetate copolymers, polyethylene, and the like as well as mixtures thereof.
The amount of natural oils or fats used in the composition can be from about 0.1% by weight to about 95% by weight. The amount of sterol or sterol derivative used in the composition can be from about 0.1% to about 10%. The amount of emulsifying surfactant used in the composition can be from about 1% by weight to about 20% by weight. The amount of humectant used in the composition can be from about 0.5% by weight to about 20% by weight. The amount of the emollient used in the composition can be from about 5% by weight to about 95% by weight. The amount of the wax used in the composition can be from about 5% by weight to about 95% by weight. The amount of the viscosity increaser used in the composition can be from about 0% by weight to about 25% by weight.
An incorporation of the composition comprises about 10% by weight of sunflower seed oil, about 0.8% by weight of soy sterol, about 1% by weight of sorbitan oleate, about 5% by weight of glycerin, about 43.2% of petrolatum, about 20% by weight of stearyl alcohol, and about 20% by weight of cerasin.
Another incorporation of the composition comprises about 10% by weight of borage oil, about 0.8% by weight of soy sterol, about 1% by weight of sorbitan oleate, about 5% by weight of glycerin, about 43.2. % of petrolatum, around 20% by weight of stearyl alcohol and around 20% by weight of cerasin.
Another incorporation of the composition comprises about 10% by weight of avocado oil, around
0. 8% by weight of soy sterol, about 1% by weight of sorbitan oleate, about 5% by weight of glycerin, about 43.2% by weight of petrolatum, about 20% by weight of stearyl alcohol, and about 20% by weight of cerasin.
Another incorporation of the composition comprises about 2% by weight of PROLIPID 141 (from International Specialty Products, of Wayne, New Jersey), about 10% by weight of sunflower seed oil, about 1% by weight of sterol from soybeans, about 1% by weight of sorbitan oleate, about 5% by weight of glycerin, about 32% by weight of petrolatum, about 15% by weight of behenyl alcohol, about 32% by weight of cerasin, and about 2% by weight of viscosity polyethylene.
Another embodiment of the composition comprises about 2% by weight of PROLIPID 141 (from International Specialty Products, of Wayne, New Jersey), about 30% by weight of sunflower seed oil, about 3% by weight of sterol from soybeans, about 5% by weight of sorbitan oleate, about 5% by weight of sorbitol, about 10% by weight of petrolatum, about 10% by weight of behenyl alcohol, about 30% by weight of ozokerite, and about 5% by weight of polyethylene.
Another incorporation of the composition comprises about 5% by weight of lanolin, about 20% by weight of sunflower seed, about 3% by weight of cholesterol, about 5% by weight of sorbitan stearate, about 5% by weight of hydrogenated starch hydrolyzate, about 2% by weight of petrolatum, about 5% by weight of octyl dodecanol, about 15% by weight of stearyl alcohol, about 30% by weight of microcrystalline wax, and about 5% by weight of vinyl acetate / ethylene copolymer.
Another incorporation of the composition comprises about 27% by weight of avocado oil, about 3% by weight of avocadin or avocado sterols, about 2% by weight of sorbitan trioleate, about 15% by weight of glycerin , about 17% by weight of petrolatum, about 18% by weight of cetyl alcohol, and about 18% by weight of cerasin.
Another incorporation of the composition comprises about 15% by weight of avocado oil, about 5% by weight of sterol esters, about 10% by weight of sorbitan trioleate, about 8% by weight of glycerin, about 2% by weight of petrolatum, about 55% by weight of a mixture of ozokerite and cetyl esters, and about 5% by weight of polyethylene. The mixture of ozokerite and cetyl esters comprises about 90% by weight of ozokerite and about 10% by weight of cetyl esters.
Another incorporation of the composition comprises about 25% by weight of borage oil, about 10% by weight of avocado or avocadin sterols, about 5% by weight of sorbitan trioleate, about 1% by weight of glycerin , about 11% by weight of petrolatum, about 10% by weight of stearyl alcohol, about 36% by weight of cerasin, and about 2% by weight of polyethylene.
Another embodiment of the composition comprises about 25% by weight of sunflower seed oil, about 3% by weight of lanasterol, about 2% by weight of sorbitan trioleate, about 5% by weight of glycerin, about 15% by weight of petrolatum, about 10% by weight of stearyl alcohol, about 10% by weight of behenyl alcohol, about 45% by weight of microcrystalline wax and about 5% by weight of polyethylene.Another incorporation of the composition comprises about 35% by weight of avocado oil, about 3% by weight of cytosterol, about 5% by weight of sorbitan trioleate, about 5% by weight of glycerin, about 1% by weight of petrolatum, around 10% by weight of stearyl alcohol, around 21% by weight of ozokerite, and about 10% by weight of polyethylene.
Another embodiment of the present invention relates to a method for increasing / restoring / maintaining the barrier function of a user's skin. The method comprises the steps of:
a) contacting a tissue or towel product on the skin of said user wherein said material comprises a skin barrier enhancer / restorer / maintainer composition that provides an enhancer / restoration / barrier maintenance benefit the skin with the transfer of the composition to the user's skin;
b) transferring at least a part of the composition during the use of the tissue or towel product;
c) repeating steps a) and b) with one or more additional tissue or towel products with sufficient frequency to increase / restore / maintain the skin barrier in an area of the skin with which the tissue product contacts or towel, in relation to the skin that is contacted with an equivalent tissue or towel product that does not comprise the skin barrier-enhancing / restorative / maintenance composition.
The skin barrier maintaining / restorative / maintaining composition of the method comprises from about 0.1% by weight to about 95% by weight of natural oils or fats, from about 0.1% by weight to about 10% by weight of sterols or sterol derivatives, from about 1% by weight to about 20% by weight of a water-in-oil emulsifying surfactant having a hydrophilic-lipophilic balance range of from about 3 to about 6, from about 0.5% by weight to about 20% by weight of humectant, from about 5 to about 95% by weight of emollient, from about 5% by weight to about 95% by weight of wax, and from about 0% by weight to about 25% by weight of viscosity increaser.
The composition can have a melting point of from about 30 ° C to about 100 ° C, the resolidified composition can have a process viscosity of greater than about 50 centipoise. The resolidified composition can have a penetration hardness of from about 5 to about 360 millimeters. The method may further comprise the use of a tissue or towel product having an enhancer / restorative / skin barrier maintenance composition by the user on each occasion of use. The method may further comprise using a tissue or towel product which does not comprise an enhancing / restorative / skin barrier maintenance composition intermittently by the user. The method may furthermore use the tissue or towel product comprising an enhancing / restorative / barrier maintenance composition of the skin by a user whose skin is compromised and with sufficient frequency to improve the skin's barrier function.
The amount of fat or natural oil or a mixture of natural oils or fats in the hydrophobic oil-based composition can be from about 0.1% by weight to about 95% by weight, more specifically from about 5% by weight. % by weight to about 75% by weight, more specifically from about 10% by weight to about 50% by weight. As used herein, the phrase "natural oils or fats" is understood as including fats, oils, essential oils, fatty acids, fatty alcohols, phospholipids, and mixtures thereof. As used herein, suitable natural fats or oils include, but are not limited to the following materials classified according to the CTFA designations.
Oils and Fats: Peach nugget oil, avocado oil, babassu oil, borage oil, butter, C12-C18 triglyceride, camellia oil, canola oil, capric / caprylic / lauric triglyceride, caprylic / capric triglyceride / linoleic, caprylic / capric / stearic triglyceride, caprylic / capric triglyceride, carrot oil, cashew nut oil, castor oil, cherry stone oil, chia oil, cocoa butter, coconut oil, liver oil of cod, corn germ oil, corn oil, cottonseed oil, triglycerides C10-C18, egg oil, epoxidized soybean oil, afternoon trilogy oil, glyceryl triacetyl hydroxystearate, glyceryl triacetyl ricinoleate, glycosphingolipids, grapeseed oil, hazelnut oil, human plancenta lipids, hybrid safflower oil, hybrid sunflower seed oil, hydrogenated castor oil, oil laurate hydrogenated castor oil, hydrogenated coconut oil, hydrogenated cottonseed oil, hydrogenated C12-C18 triglycerides, hydrogenated fish oil, hydrogenated shortening, hydrogenated Menhaden oil, hydrogenated bison oil, hydrogenated orange coarse oil, pomace oil hydrogenated palm oil, hydrogenated palm oil, hydrogenated peanut oil, hydrogenated shark liver oil, hydrogenated soybean oil, hydrogenated bait, hydrogenated vegetable oil, lard, lauric / palmitic / oleic triglyceride, lanolin and lanolin derivatives, lesquerella, linseed oil, macadamia nut oil, beaten soybean oil, prairie foam seed oil, Menhaden oil, bicion oil, moringa oil, mortierella oil, bovine animal leg oil, triglyceride oleic / linoleic, triglyceride oleic / palmitic / lauric / myristic / linoleic, oleostearin, olive peel oil, olive oil , omental lipids, coarse orange oil, palm kernel oil, palm oil, peach kernel oil, peanut oil, Penjawar Djambi oil, pentadesma butter, phospholipids, pistachio nut oil, lipid placenta, cola seed oil, bran and rice oil, safflower oil, sesame oil, shark liver oil, Shea butter, soybean oil, sphingolipids, sunflower seed oil, sweet almond oil, resin oil bait, tribehenin, tricaprin, tricaprylin, triheptanoin, trihydroxymethoxystearin, trihydroxystearin, triisononanoin, triisostearin, trilaurin, trilinolein, trinolenin, trimiristin, trioctanoin, triolein, tripalmitin, tricebasine, tristearin, trindecanoin, vegetable oil, walnut oil, bran lipids and wheat, wheat germ oil, Zadoari oil, and the like, as well as mixtures thereof.
Fatty acids: arachidic acid, arachidonic acid, behenic acid, capric acid, capric acid, caprylic acid, coconut acid, corn acid, cottonseed acid, hydrogenated coconut acid, hydrogenated Menhaden acid, hydrogenated bait acid, hydroxystearic acid, isostearic acid, lauric acid, linoleic acid, linolenic acid, flaxseed acid, myristic acid, oleic acid, palmitic acid, palm kernel acid, pelargonic acid, ricinoleic acid, soy acid, stearic acid, oil acid resin, bait acid, undecanic acid, undecylenic acid, wheat germ acid and the like as well as mixtures thereof.
Fatty alcohols: Behenyl alcohol, alcohols
C9-C11? alcohols C12-C13, C12-C15 alcohols, C12-C16 alcohols, C14-C15 alcohols, caprylic alcohol, cetearyl alcohol, cetyl alcohol, coconut alcohol, decyl alcohol, hydrogenated bait alcohol, lanolin alcohol, lauryl alcohol, myristyl alcohol , oleyl alcohol, palm alcohol, palm kernel alcohol, stearyl alcohol, bait alcohol, tridecyl alcohol and the like as well as mixtures thereof.
Essential oils: Anise oil, balsam mint oil, basil oil, bee balm oil, bergamot oil, birch oil, bitter almond oil, bitter orange oil, calendula oil, california nut oil , caraway oil, cardamom oil, chamomile oil, cinnamon oil, wild sage oil, clove oil, coriander oil, cypress oil, eucalyptus oil, fennel oil, gardenia oil, oil geranium, ginger oil, grapefruit oil, hops oil, Hyptis oil, Indian bush oil, jasmine oil, hemerob oil, kiwi oil, bay oil, lavender oil, lemon grass oil, lemon oil, linden oil, ligure oil, tangerine orange oil, matriacaria oil, musk rose oil, nutmeg oil, olibanum, orange blossom oil, orange oil, patchouli oil, pennyroyal oil, oil d e peppermint, pine oil, pine tar oil, rose hip oil, rosemary oil, rose oil, rue oil, sage oil, zambuco oil, sandalwood oil, sassafras oil, fir oil white, spearmint oil, sweet marjoram oil, sweet violet oil, tar oil, tea tree oil, thyme oil, wild mint oil, yarrow oil, Ylang Ylang oil and the like, as well as mixtures thereof.
Preferred natural oils include, but are not limited to: avocado oil, peach oil, babazu oil, borage oil, camellia oil, canola oil, castor oil, coconut oil, corn oil, seed oil cotton, evening primrose oil, hydrogenated cottonseed oil, hydrogenated palm kernel oil, beaten soybean oil, prairie foam oil, palm kernel oil, phospholipids, colasa seed oil, palmitic acid, stearic acid, linoleic acid, rose hip oil, sunflower oil, soybean oil, PROLIPID 141 (proprietary mixture of glyceryl stearate, fatty acids, fatty alcohols, and phospholipids from International Specialty Products, Wayne, New Jersey), derivatives of natural fats or oils (such as stearyl alcohol, lauryl alcohol, myristyl alcohol, behenyl alcohol, and the like), and the like as well as mixtures thereof.
The amount of sterol or sterol derivative or mixtures of sterols or sterols derivatives in the hydrophobic oil-based composition can be from about 0.1 to about 10% by weight, more specifically from about 0.5 to about 5% by weight and even more specifically from about 0.8% by weight to about 1% by weight. As used herein, suitable sterols and sterol derivatives include, but are not limited to the following materials: β-sterols which have a tail on position 17 and which do not have polar groups, eg cholesterol, cytosterol, stigmasterol, and ergosterol, as well as cholesterol / lanosterol C10-C30 esters, cholecalciferol, cholesteryl hydroxystearate, cholesteryl isostearate, cholesteryl stearate, 7-dehydrocholesterol, dihydrocol is terol, dihydrocholesterol-octylcanocano, dihydrolanosterol, dihydrolanosteril, octylcanocano, ergocalciferol, resin, soy sterol acetate, lanasterol, soy sterol, avocado sterols, sterol esters, and the like and sources of natural extracts (such as avocadin and lanolin), and the like, as well as mixtures thereof.
The amount of surfactant / surfactant combinations oil-in-water emulsifiers have a range of hydrophilic / lipophilic balance of from about 3 to about 6 in the hydrophobic oil-based composition can be from about 1% by weight to about 20% by weight, more specifically from about 2% by weight to about 10% by weight, even more specifically from about 3 to about 8% by weight. Emulsifying surfactants are typically employed in cosmetic preparations to form multi-component emulsions. The immiscible phase, such as water and dispersible / water soluble materials, is dispersed as droplets in the continuous phase, such as an oil.
Preferred surfactants include, but are not limited to: sorbitan monooleate, glyceryl stearate, sorbitan sequioleate, sorbitan trioleate, sorbitan stearate, sorbitan tristearate, and the like, as well as mixtures thereof.
The amount of humectant in the hydrophobic oil-based composition can be from about 0.5 to about 20% by weight, more specifically from about 1 to about 15% by weight and even more specifically from about 3% by weight. to around 10% by weight. Moisturizers are typically cosmetic ingredients used to increase the water content of the tip layers of the skin. This group of materials includes primarily hydroscopic ingredients. As used herein, suitable humectants include, but are not limited to the following materials: acetamide MEA, Aloe Vera gel, arginine PCA, chitosan PCA, copper PCA, glycerides of maiz, dimethyl imidazolidinone, fructose, glucamine, glucose, glutamate glucose, glucuronic acid, glutamic acid, glycereth-7, glycereth-12, glycereth-20, glycereth-26, glycerin, honey, hydrogenated honey, hydrogenated starch hydrolyzate, hydrolyzed corn starch, lactamide MEA, lactic acid, lysine lactose PCA, mannitol, methyl gluceth-10, methyl 'gluceth-20, PCA, PEG-2 lactamide, PEG-10 propylene glycol, sugar condensate polyamino, PCA potassium, propylene glycol, propylene glycol citrate, hydrolyzed saccharin, saccharin isomerate, aspartate sodium, sodium lactate, sodium PCA, sorbitol, lactate TEA, TEA-PCA, urea, xylitol and the like as well as mixtures thereof.
Preferred humectants include but are not limited to: glycerin, hydrogenated starch hydrolyzate, propylene glycol, sodium PCA, sodium lactate, sorbitol and the like as well as mixtures thereof.
The amount of emollient in the hydrophobic, oil-based composition can be from about 5 to about 95% by weight, more specifically from about 15% by weight to about 80% by weight and even more specifically from about 20% by weight to about 65% by weight. As used herein, suitable emollients include, but are not limited to the following materials: mineral oil, mineral jelly, petrolatum, cosmetic esters (isopropyl palmitate, isopropyl myristate, isopropyl adipate, C12-C14 benzoate, stearyl benzoate, behenyl benzoate, octyl palmitate and the like) glyceryl esters, alkoxylated carboxylic acids, alkoxylated alcohols, fatty alcohols (lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, cetearyl alcohol, behenyl alcohol, octyl dodecanol and the like), lanolin and lanolin derivatives, natural oils , base oils, silicones, organofunctional silicones, hydrogenated vegetable oils, and the like as well as mixtures thereof.
Preferred emollients include but are not limited to: mineral oil, petrolatum, cosmetic esters, fatty alcohols and the like as well as mixtures thereof.
The amount of wax in the hydrophobic, oil-based composition can be from about 5% by weight to about 95% by weight, more specifically from about 10 to about 75% by weight, and even more specifically from from about 20% by weight to about 60% by weight. As used herein, suitable waxes include, but are not limited to the following materials: natural and synthetic waxes, such as laurel berry wax, beeswax, C30 alkyl dimethicone, candelilla wax, carnuaba, ceresin, cetil esters, hydrogenated cottonseed oil, hydrogenated jojoba oil, hydrogenated jojoba wax, hydrogenated microcrystalline wax, bran wax and hydrogenated corn, japan wax, jojoba butter, jojoba esters, jojoba wax, lanolin wax , microcrystalline wax, bizon wax, montan acid wax, montan wax, ouricury wax, ozokerite, paraffin, beeswax PEG-6, beeswax PEG-8, bran wax and rice, lacquer wax, wax spent grain, sterile synthetic dimethicone beeswax, synthetic candelilla wax, synthetic carnuba wax, synthetic japan wax, synthetic jojoba wax, synthetic wax, and the like, as well as mixtures thereof.
Preferred waxes include, but are not limited to: carnuba waxes, cerasin, cetyl esters, microcrystalline wax, montan wax, ozokerite, synthetic wax and the like as well as mixtures thereof.
Optionally, the amount of viscosity increaser in the hydrophobic oil-based composition can be from about 0% by weight to about 25% by weight, more specifically from about 5% by weight to about 20% by weight. weight, and even more specifically from about 10 to about 15% by weight. As used herein, suitable viscosity builders include, but are not limited to the following materials: the group consisting of polyolefin resins, polyolefin polymers, ethylene / vinyl acetate copolymers, polyethylene and the like as well as mixtures thereof .
The resolidification of the hydrophobic composition based on melted oil can occur almost instantaneously, without the need for external cooling means, such as chill rolls, if the composition is heated to a temperature only slightly above or at the melting point of the composition. However, external media such as chill rolls, either before or after the application of the melt can be used if desired to accelerate the resolidification. Such instant resolidification tends to prevent the penetration of the composition into the tissue and to retain it on the surface of the tissue, which is advantageous. For example, the temperature of the molten composition may advantageously be above the melting point of about 10 ° C or less, more specifically about 5 ° C or less and even more specifically about 2 ° C or less. As the temperature of the molten composition approaches the melting point, the viscosity of the molten composition generally increases, which further increases the tendency of the molten composition to be retained on the surface.
For the purposes given here, the "melting point" is the temperature at which the majority of the melt occurs, recognizing that the melt actually occurs over a range of temperatures. The melting point of the compositions of this invention can be from about 30 ° C to about 100 ° C, more specifically from about 40 ° C to about 90 ° C, and even more specifically from about 80 ° C. 50 ° C to around 70 ° C.
In addition, for the purposes given here "penetration hardness" is the penetration of needle in millimeters according to ASTM D 1321, "Penetration of Oil Wax Needle". The lower needle penetration hardness values correspond to the harder materials. The penetration hardness of the compositions of this invention can be from about 5 millimeters to 360 millimeters, more specifically from about 5 to about 200 millimeters, more specifically from about 5 to about 150 millimeters, and yet more specifically from around 5 millimeters to around 100 millimeters. (Formulas that have a needle penetration hardness greater than 360 millimeters can not be measured using the ASTM D 1321 method).
The hardness of the formulas of this invention is important for two reasons. First, the softer the formula, the more mobile the formula will be, making the formula more likely to migrate to the inner layers of the tissue, which is undesirable. Second, softer formulas tend to be more greasy / oily to the touch which is also less desirable. In general, formulas that have a needle penetration hardness of from about 200 millimeters to 360 millimeters feel creamy to slightly greasy with less softness (depending on the additives). Formulas that have needle penetration hardness values of from about 5 millimeters to about 200 millimeters feel silky to creamy and very soft (depending on the additives).
The melt viscosity point and / or the process temperature viscosity of the formulas or compositions of this invention is important for two reasons: first, the higher the viscosity of the melting point or the viscosity of the process temperature applied to the outer surface of the diaper lining, the formula will be less feasible to penetrate through the stratum or inner layers of the tissue. The less penetrate the formula through the tissue, the more there will be on the surface of the tissue where it can be easily transferred to the surface of the skin of the users. Second, the higher the viscosity of the formula mentioned above or the melting point of the formula, the less likely it is that the formula will migrate to adverse or typical storage conditions.
In order to better increase benefits for consumers, additional ingredients can be used. The class of ingredients and their corresponding benefits include, without limitation, anti-acne assets (a drug product used to reduce the number of acne spots, acne pimples, black heads and white heads); agents against frothing (reduce the tendency to foam during processing); antimicrobial assets; antifungal assets; antiseptic assets; antioxidants (integrity of the product to avoid oxidation of natural oils or other ingredients of the formula); astringent-cosmetics (induce a tightening or scorching sensation on the skin); drug-astringent (a drug product which verifies exudate, discharge or bleeding when applied to the skin or mucous membrane and works by a coagulating protein); biological additives (increase the functioning or attraction to the consumer of the product including vitamins); dyes (impart color to the product); deodorants (reduce or eliminate unpleasant odor and protect against the formation of bad odor on body surfaces); emollients (help maintain the smooth, smooth and supple appearance of the skin by its ability to remain on the surface of the skin or in the stratum corneum to act as lubricants, to reduce scaling and to improve the appearance of the skin); film formers (to retain the active ingredients on the skin by producing a continuous film on the skin with drying); fragrances (attraction to the consumer); natural moisturizing agents (NMF) and other skin moisturizing ingredients known in the art; skin conditioning agents; skin exfoliating agents (ingredients that increase the rate of cell change of the skin such as alpha hydroxy acids and beta hydroxy acids); skin protectors (a drug product which protects the injured or exposed skin or the surface of the mucous membrane from harmful or annoying stimuli); solvents (liquids used to dissolve the components found useful in cosmetics or drugs); sunscreens (ingredients that absorb at least 85% of the light in the ultraviolet range at wavelengths of 290 to 420 nanometers, but transmit ultraviolet light at wavelengths longer than 420 nanometers); and surfactants (as cleaning agents, solubilizing agents, suspending agents, and wetting agents).
The aggregate of total tissue of the composition can be from about 0.5% by weight to about 40% by weight, more specifically from about 5 to about 30% by weight, and more specifically from about 10% by weight. about 15% by weight, based on the weight of the tissue. The amount of aggregate will depend on the desired effect of the composition on the attributes of the product and the specific composition. A preferred method for uniformly applying the heated composition to the tissue tissue surface is rotogravure printing, either direct or indirect
(Off-center) because this is a more accurate and accurate printing process and offers maximum control of composition distribution and transfer rate. However, other printing methods may be used, but not limited to flexographic printing or spraying such as WEKO.
As used herein, all recited ranges of quantities, temperatures, molecular weights and penetration hardness are intended to include all sub-ranges within the ranges quoted, even if this is not specifically stated.
The compositions of the present invention may be applied to the entire exterior surface or surfaces of the tissue or towel product or portions thereof. The compositions of the present invention can be applied non-uniformly to the outer surface of the tissue or towel product. The term "non-uniformly" as used herein, refers to the amount, the pattern of distribution, the thickness of the application, the uncovered areas, or the like, for which the composition may be varied on the surface or surfaces outside of the tissue or towel product.
Also as used herein, a "tissue product" can be a facial tissue, a sanitary bathroom tissue, a paper towel, a paper napkin or the like. The tissue products of this invention can be one-stratum, two-stratus, three-stratum or more. In all cases, the composition is applied to one or both of the exterior surfaces of the product after the product has dried. The composition can be applied after the strata are put together or before the strata are put together. The individual layers can be layered or mixed (homogeneous), they can be creped or non-creped, dried continuously or wet pressed.
And emplos
The following examples are presented to provide a more detailed understanding of the invention. The particular materials and parameters are exemplary and are not intended to limit the scope of the invention.
The following formulas are used in examples 1-4:
Formula 1 Percent by Weight
Petrolatum 93.7% Glycerin 5% PROLIPID 141 1.0% (International Specialty Products, Wayne, New Jersey)
0.3% tocopherol acetate
Formula 2 Percent by Weight
Petrolatum 88.7% Glycerin 5% PROLIPID 141 1.0% (International Specialty Products, Wayne, New Jersey) Tocopherol acetate 0.3% Avocadin (CRODA) 5.0%
Formula 3 Percent by Weight
Petrolatum 83.7% Glycerin 5% Tocopherol acetate 0.3% Sunflower oil 9.2% Soybean sterol 0.8% PROLIPID 141 1.0% (International Specialty Products, Wayne, New Jersey) Formula 4 Percent by Weight
100% Petrolatum
Formula 5 Percent by Weight
Petrolatum 85.4% Glycerin 5% Glycerin Mono-Oleate 3% Borage Oil 3% Soy Sterol 3% Aloe 0.3% Tocopherol Acetate 0.3%
Formula 6 Percent by Weight
Petrolatum 86.4% Glycerin 5% Glycerin Mono-Oleate 3% Borage Oil 3% Soy Sterol 1% PROLIPID 141 1.0% (International Specialty Products, Wayne, New Jersey Aloe 0.3% Tocopherol Acetate 0.3%
Formula 7 Percent by Weight Petrolatum 44% Mineral oil 10.8% Cerasin 10% Stearyl Alcohol 25% Isopropyl Palmitate 3% Sunflower Oil 3% Soy Sterol 3% Dimethicone 1% Aloe Extract 0.1% Vitamin E Acetate 0.1%
Formula 8 Percent by Weight
Petrolatum 36% Mineral oil 10.8% Cerasin 10% Stearic acid 25% Glycerin 5% Glyceryl mono-oleate 3% Isopropyl Palmitate 3% Sunflower oil 3% Soybean 3% Dimethicone 1% Aloe extract 0.1% Vitamin E acetate 0.1% Use 1
The formulas enriched with lipid for the treatment of the absorbent tissue promote the repair of the barrier as measured by the loss of transepidermal water.
All the studies were carried out in a controlled temperature and humidity room (71 ° F ± 5 ° F, 40% + 5% relative humidity).
Loss of Transepidermal Water (TEWL)
The palmar forearm of 24 panelists was scraped with an emery cloth to increase the levels of transepidermal water loss at 18 g / m2 hour-20 g / m2 h. After the abrasion, fifteen microliters of a formula enriched with lipid was applied topically to the palmar forearm. Transepidermal water loss measurements were obtained using a Dermalab evaporimeter instrument at 1, 2 and 4 hours.
The mean transepidermal water loss values are expressed in Table 1. Repeated measurements of ANOVA were used to adjust the repeated transepidermal water loss measurements.
Table 1: Results of Transepidermal Water Loss (g / m2 / hour) - Absorbent Tissue Formulas Enriched with PIR Lipid 1 Hour 2 Hours 4 Hours Average Medium Medium Medium Formula 1 19.8 6.6 * 6.6 * 7.9 * Formula 2 18.3 6.4 * 6.6 * 7.3 * Formula 3 19.2 6.5 * 6.5 * 7.1 * Not Treated 19.2 15.2 14.3 14.3 * Denotes significantly different than the untreated site.
The aforementioned data clearly show that lipid-enriched formulas improve skin barrier repair.
Example 2
The formulas enriched with lipid for the treatment of absorbent tissue increase the wetting of the skin as measured by conduction.
All the studies were carried out in a controlled temperature and humidity room (71 ° F + 5 ° F, 40% + 5% relative humidity).
Driving
Fifteen microliters of formula enriched with lipid for an absorbent tissue were applied topically to the palmar forearm. The conduction measurements were obtained using the Skicon instrument at 1, 2, 4 and 6 hours. The mean conduction values are expressed in Table 2. A comparison was applied in the direction of the pair for each period of time using univariate ANOVAs.
Table 2: Driving - Formula Enriched with Lipid for Tissues
Absorbents Baseline 1 Hour 2 Hours 4 Hours 6 Hours Average Medium Medium Medium Medium Formula 1 202 370 * 357 * 335 * 310 * Formula 2 220 344 * 349 * 333 * 319 * Formula 3 220 342 * 340 * 333 * 320 * No Treaty 200 220 235 232 223
* Denotes significantly different than the untreated site.
The aforementioned data clearly demonstrate that lipid-enriched formulas improve skin barrier wetting.
Example 3
The formulas enriched with lipid for the treatment of absorbent tissue increase the wetting of the skin as measured by conduction.
All the studies were carried out in a controlled temperature and humidity room (71 ° F + 5 ° F, 40% + 5% relative humidity).
Driving
Fifteen microliters of absorbent tissue formula enriched with lipid were applied topically to the palmar forearm. The conduction measurements were obtained at 1, 2, 4 and 6 hours. The average conduction values for the baseline, time points of 4 and 6 hours are expressed in Table 3. A comparison was applied in the direction of the pair for each period of time using non-variable ANOVAs.
Table 3: Conduction - Absorbent Tissue Formulas Baseline 4 Hour 6 Hours Average Medium Medium Formula 4 187 243 247 Formula 5 179 281 * 289 * Formula 6 195 295 * 297 * Not Treated 194 210 215
* Denotes significantly different than the untreated site.
The aforementioned data clearly demonstrate that lipid-enriched formulas improve skin barrier wetting.
Example 4
Repetitive cleaning with an absorbent tissue treated with a formula enriched with hydrophobic lipid reduces barrier damage compared to an untreated absorbent tissue.
Absorbent tissue treated with a formula enriched with hydrophobic lipid was cleaned repetitively on the side of the face to determine the extent of barrier damage as measured by transepidermal water loss. The study consisted of repetitively cleaning the face of 10 panelists with the absorbent tissues for a total of 15 cleaning cycles. The cleaning cycles were ordered in time at approximately 30 minutes of separation with each cleaning cycle consisting of 20 cleaning cloths. A transepidermal water loss reading of the baseline and the transepidermal water loss readings after every two cleaning cycles were obtained from each panelist using the Dermalab evaporimeter. The change in transepidermal water loss between cleaning cycles was determined for each treatment. * Denotes statistically different than untreated absorbent tissue.
Repetitive cleaning with absorbent tissues treated with hydrophobic lipid enriched formulas results in less skin barrier damage compared to untreated absorbent tissue.
Thus, the examples representatively illustrate that the hydrophobic lipid-enriched composition of the present invention can provide absorbent tissue products having improved softness as well as improved protection of skin barrier function. Thus, different aspects of the present invention can advantageously provide absorbent tissue products which, when compared to conventional tissue products, are softer and have improved protection of the skin barrier function. Such absorbent tissue products can advantageously be used for absorbent tissue products, such as facial tissue, bath tissue, paper towels and the like.
Although the invention has been described in detail with respect to the specific aspects thereof, it will be appreciated by those skilled in the art, upon achieving an understanding of the foregoing, that alterations, variations and equivalents of these aspects can easily be conceived. Therefore, the scope of the present invention should be assessed as that of the appended claims and of any equivalents thereof.
Claims (54)
1. A tissue or towel product having two outer surfaces, wherein one or both of the outer surfaces of said product has a composition that increases the skin barrier comprising: from about 0.1% by weight to about 95% by weight of natural oils or fats; from about 0.1% by weight to about 10% by weight of sterols or sterol derivatives; from about 1% by weight to about 20% by weight of a water-in-oil emulsifying surfactant having a hydrophilic-lipophilic balance range of from about 3 to about 6; from about 0.5 to about 20% by weight of the humectant; from about 5 to about 95% by weight of emollient; from about 5 to about 95% by weight of wax; and from about 0% by weight to about 25% by weight of the viscosity increaser.
2. The product, as claimed in clause 1, characterized in that said composition has a melting point of from about 30 ° C to about 100 ° C.
3. The product, as claimed in clause 1, characterized in that said composition has a penetration hardness of from about 5 millimeters to about 360 millimeters.
4. The product, as claimed in clause 1, characterized in that the aggregate amount of said composition is from about 0.5 to about 30% by weight based on the weight of said product.
5. The material, as claimed in clause 1, characterized in that the aggregate amount of said composition is from about 0.1 grams per square meter (g / m2) to about 30 grams per square meter of said material.
6. The product, as claimed in clause 1, characterized in that said fat or natural oil is sunflower oil.
7. The product, as claimed in clause 1, characterized in that said natural fat or oil is borage oil.
8. The product, as claimed in clause 1, characterized in that said natural fat or oil is avocado oil.
9. The product, as claimed in clause 1, characterized in that said sterol or sterol derivative is soy sterol.
10. The product, as claimed in clause 1, characterized in that said sterol or sterol derivative is cholesterol.
11. The product, as claimed in clause 1, characterized in that said sterol or sterol derivative is latherterol.
12. The product, as claimed in clause 1, characterized in that said humectant is glycerin.
13. The product, as claimed in clause 1, characterized in that said humectant is sorbitol.
14. The product, as claimed in clause 1, characterized in that said humectant is hydrolyzed from hydrogenated starch.
15. The product, as claimed in clause 1, characterized in that said emulsifying surfactant is sorbitan oleate.
16. The product, as claimed in clause 1, characterized in that said emulsifying surfactant is glycerin stearate.
17. The product, as claimed in clause 1, characterized in that said emulsifying surfactant is sorbitan stearate.
18. The product, as claimed in clause 1, characterized in that said emollient is petrolatum.
19. The product, as claimed in clause 1, characterized in that said emollient is mineral oil.
20. The product, as claimed in clause 1, characterized in that said emollient is stearyl alcohol.
21. The product, as claimed in clause 1, characterized in that said wax is waxen.
22. The product, as claimed in clause 1, characterized in that said wax is ozokerite.
23. The product, as claimed in clause 1, characterized in that said wax is microcrystalline wax.
24. The product, as claimed in clause 1, characterized in that said viscosity enhancer is ethylene / vinyl acetate copolymer.
25. The product, as claimed in clause 1, characterized in that said viscosity increaser is polyethylene.
26. A method for making a tissue or towel product having two exterior surfaces comprising: a) heating a composition that increases the skin barrier comprising a natural oil or fat, a sterol or sterol derivative, a humectant, an emulsifying surfactant having a hydrophilic-lipophilic balance range of from about 3 to about 6, an emollient, a wax, a viscosity increaser at a temperature above the melting point of said composition, which causes said composition to melt; b) applying said molten composition to one or both surfaces of the tissue of tissue or towel; and c) resolidifying said molten composition.
27. The method, as claimed in clause 26, characterized in that it has a said melting point of from about 30 ° C to about 100 ° C.
28. The method, as claimed in clause 26, characterized in that said resolidified composition has a penetration hardness of from about 5 to about 360 millimeters.
29. The method, as claimed in clause 26, characterized in that said molten composition is applied by printing.
30. A skin barrier improving composition comprising from about 0.1 to about 95% by weight of natural oils or fats, from about 0.1% by weight to about 10% by weight of sterol or a derivative of sterol, from about 1% by weight to about 20% by weight of an oil-in-water emulsifying surfactant with a hydrophilic-lipophilic balance range of from about 3 to about 6, from about 0.5% by weight to about 20% by weight of the humectant, from about 5% by weight to about 95% by weight of an emollient, from about 5 to about 95% by weight of wax and from about 0% by weight to about 25% by weight of the viscosity increaser.
31. The composition, as claimed in clause 30, characterized in that said composition has a melting point of from about 30 ° C to about 100 ° C.
32. The composition, as claimed in clause 30, characterized in that said resolidified composition has a penetration hardness of from about 5 millimeters to about 360 millimeters.
33. The composition, as claimed in clause 30, characterized in that said fat or natural oil is selected from the group consisting of: avocado oil, peach oil, babassu oil, borage oil, camellia oil, oil cañola, castor oil, chamomile, coconut oil, corn oil, cottonseed oil, evening primrose oil, hemp seed, hydrogenated cottonseed oil, hydrogenated palm kernel oil, soybean oil beaten, prairie foam oil, palm kernel oil, phospholipids, kolaza seed oil, palmitic acid, stearic acid, linoleic acid, rose hip oil, safflower, sunflower oil, sonya bean oil, almond oil sweet or derivatives of fats or natural oils such as stearyl alcohol, lauryl alcohol, myristyl alcohol and behenyl alcohol and mixtures thereof.
34. The composition, as claimed in clause 30, characterized in that said sterol or sterol derivative is selected from the group consisting of: cholesterol, cytosterol, stigmaterol, ergosterol, latherterol, soy steroid, avocado sterols, sterols, esters and mixtures thereof .
35. The composition, as claimed in clause 30, characterized in that said sterol is selected from natural extracts containing sterols or sterol derivatives selected from the group consisting of: lanolin, avocadine, and mixtures thereof.
36. The composition, as claimed in clause 30, characterized in that said emulsifying surfactant is selected from the group consisting of: sorbitan oleate, sorbitan sesquioleate, glyceryl stearate, sorbitan stearate, sorbitan tristearate, sorbitan trioleate and mixtures thereof.
37. The composition, as claimed in clause 30, characterized in that said humectant is selected from the group consisting of: glycerin, hydrogenated starch hydrolyzate, propylene glycol, sodium PCA, sodium lactate, sorbitol and mixtures thereof.
38. The composition, as claimed in clause 30, characterized in that said emollient is selected from the group consisting of: mineral oil, petrolatum, stearyl alcohol, cetearyl alcohol, cetyl alcohol, behenyl alcohol, octyldodecanol, cosmetic esters and mixtures thereof. same.
39. The composition, as claimed in clause 30, characterized in that said wax is selected from the group consisting of: carnuba, cerasin, cetyl esters, microcrystalline wax, montan wax, ozokerite, synthetic wax, and mixtures thereof.
40. The composition, as claimed in clause 30, characterized in that said viscosity increaser is selected from the group consisting of: polyolefin resins, polyolefin polymers, ethylene / vinyl acetate copolymers, polyethylene and mixtures thereof.
41. The composition, as claimed in clause 30, characterized in that the amount of said natural fats or oils is from about 0.1% by weight to about 95% by weight.
42. The composition, as claimed in clause 30, characterized in that the amount of said sterol or sterol derivative is from about 0.1% to about 10%.
43. The composition, as claimed in clause 30, characterized in that the amount of said emulsifying surfactant is from about 1 to about 20% by weight.
44. The composition, as claimed in clause 30, characterized in that the amount of said humectant is from about 0.5% by weight to about 20% by weight.
45. The composition, as claimed in clause 30, characterized in that the amount of said emollient is from about 5% by weight to about 95% by weight.
46. The composition, as claimed in clause 30, characterized in that the amount of said wax is from about 5% by weight to about 95% by weight.
47. The composition, as claimed in clause 30, characterized in that the amount of said viscosity increaser is from about 0 to about 25% by weight.
48. A method for increasing / restoring / maintaining the barrier function of a user's skin comprising the steps of: a) contacting a tissue or paper towel product on said skin of said user wherein said product comprises a skin barrier enhancing / restorative / maintaining composition that provides an enhancer / restoration / maintenance benefit skin barrier with the transfer of said composition to said skin of the user; b) transferring at least a part of said composition during the use of said product or towel tissue; and c) repeating steps a) and b) with one or more additional tissue or paper towel products with sufficient frequency to increase / restore / maintain said skin barrier in an area of the skin that has been contacted by said material of lining or of tissue, in relation to the skin that is contacted with an equivalent tissue or towel product that does not comprise said skin enhancing / restorative / maintenance barrier composition. wherein said skin barrier maintaining / restorative / maintenance composition comprises: from about 0.1% by weight to about 95% by weight of natural oils or fats, from about 0.1% by weight to about 10% by weight of sterols and sterol derivatives, from about 1% by weight to about 20% by weight of a water-in-oil emulsifying surfactant that has a range of hydrophilic-lipophilic balance of from about 3 to about 6, from about 0.5% by weight to about 10% by weight of humectant, from about 5 to about 95% by weight of emollient , from about 5% by weight to about 95% by weight of wax, and from about 0% by weight to about 25% by weight of viscosity increaser.
49. The method, as claimed in clause 48, characterized in that said composition has a melting point of from about 30 ° C to about 100 ° C.
50. The method, as claimed in clause 48, characterized in that said resolidified composition has a process viscosity greater than about 50 centipoise.
51. The method, as claimed in clause 48, characterized in that said resolidified composition has a penetration hardness of from about 5 to about 360 millimeters.
52. The method, as claimed in clause 48, characterized in that said tissue or towel product comprises said increase / restoration / skin barrier maintenance composition is used by said user on each occasion of use.
53. The method, as claimed in clause 48, characterized in that said tissue or towel product which does not comprise an increase / restoration / skin barrier maintenance composition is used intermittently by said user.
54. The method, as claimed in clause 48, characterized in that said tissue or towel product comprising said skin barrier-enhancing / restorative / maintenance composition is used by a user whose skin is compromised and are used with a sufficient frequency to improve the barrier function of the skin. SUMMARY A skin barrier enhancing tissue product, such as a facial tissue, a sanitary tissue for bath or paper towels and the like, can be made by applying, on the surface or surfaces of the tissue, an hydrophobic, oil-based composition. melted and enriched with lipid comprising a fat or natural oil, a sterol or a sterol derivative, an emulsifying surfactant having a hydrophilic-lipophilic balance range of from about 3 to about 6, a humectant, an emollient, a wax, and a viscosity increaser, and then resolidifying the composition to form a distribution of solid composition on the surface or surfaces of the tissue.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/130,900 | 1999-04-23 | ||
US09/379,777 | 1999-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01009992A true MXPA01009992A (en) | 2002-05-09 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU768087B2 (en) | Skin-friendly absorbent articles and compositions | |
US6534074B2 (en) | Absorbent articles providing skin health benefits | |
RU2246319C2 (en) | Wet napkins favorably treating skin | |
KR100668022B1 (en) | Wet Wipes Having Skin Health Benefits | |
US5763497A (en) | Oil-in-water type cosmetic composition | |
US6475197B1 (en) | Absorbent articles having skin health benefits | |
US20030077962A1 (en) | Absorbent tissues providing skin barrier enhancement | |
KR100676794B1 (en) | Absorbent Tissues Providing Skin Barrier Enhancement | |
KR20120093393A (en) | Wipe article comprising lotion composition comprising omega-6 fatty acid | |
EA004662B1 (en) | Vesicle forming skin oil containing w/o emulsifiers with a hydrophilic-lipophilic balance of 2-6, method for the production and use thereof | |
WO2000064501A1 (en) | Skin-friendly absorbent articles and compositions | |
US7309496B2 (en) | Composition | |
WO2000064409A1 (en) | Skin barrier enhancing absorbent tissues | |
WO1998013436A1 (en) | Humectant composition, base containing the same, and cosmetic material or external preparation containing said humectant composition | |
MXPA01009992A (en) | Absorbent tissues providing skin barrier enhancement | |
MXPA01010761A (en) | Skin barrier enhancing absorbent tissues | |
JP2972345B2 (en) | Oil-in-water type cosmetic composition | |
JP2021070686A (en) | Emulsion cosmetic | |
JP3502702B2 (en) | Water-in-oil emulsion cosmetics | |
MXPA01010759A (en) | Skin-friendly absorbent articles and compositions | |
JPH10291925A (en) | Skin cosmetic | |
ZA200107953B (en) | Wet wipes having skin health benefits. | |
MXPA01010758A (en) | Skin-friendly absorbent articles and compositions | |
JPH08113527A (en) | Emulsified type skin cosmetic |